NASDAQ:AMPH | News — Page 2 | Amphastar Pharmaceuticals, Inc.

AMPH News — Page 2

Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.

DateTypePublisherHeadlineSummary
2015-03-24Current reportSEC filingAmphastar Pharmaceuticals, Inc. filed Form 8-KAmphastar Pharmaceuticals, Inc. filed Form 8-K covering items 2.02,9.01.
2014-11-12Current reportSEC filingAmphastar Pharmaceuticals, Inc. filed Form 8-KAmphastar Pharmaceuticals, Inc. filed Form 8-K covering items 2.02,9.01.
2014-08-12Current reportSEC filingAmphastar Pharmaceuticals, Inc. filed Form 8-KAmphastar Pharmaceuticals, Inc. filed Form 8-K covering items 2.02,9.01.
2014-08-06Current reportSEC filingAmphastar Pharmaceuticals, Inc. filed Form 8-KAmphastar Pharmaceuticals, Inc. filed Form 8-K covering items 1.01.
2014-07-01Current reportSEC filingAmphastar Pharmaceuticals, Inc. filed Form 8-KAmphastar Pharmaceuticals, Inc. filed Form 8-K covering items 5.03,9.01.